Low dose of azathioprine is effective to induce and maintain remission in active Crohn disease: A prospective observational study

Azathioprine (AZA) 2 to 2.5 mg/kg/d is recommended for European patients with Crohn disease (CD), but several Asian studies reported that low dose of AZA was also effective to treat CD. To confirm those observations, we perform this prospective observational study to compare the efficacy and safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Xiaoxian, Wang, Tianrong, Shen, Jun, Ran, Zhihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112906/
https://www.ncbi.nlm.nih.gov/pubmed/30142769
http://dx.doi.org/10.1097/MD.0000000000011814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112906/
https://www.ncbi.nlm.nih.gov/pubmed/30142769
http://dx.doi.org/10.1097/MD.0000000000011814

Ejemplares similares